2010 annual financial data
Halozyme Therapeutics 2010 Operating margin
Direct answer
Operating margin was -398.25%.
Operating income was -54,257,632 USD and net income was -53,241,650 USD.
Operating cash flow was -45,385,506 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,624,115 USD
- Operating income
- -54,257,632 USD
- Net income
- -53,241,650 USD
- Operating cash flow
- -45,385,506 USD